Nephroblastoma Clinical Trial
Official title:
Therapeutic Recommendations for the Treatment of Children With Nephroblastoma in Africa.
The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.
The study is based on results form 2 previous studies carried out by the GFAOP. This study aims to evaluate the capacity of units to follow the recommendations in the protocol. It will look mainly at treatment compliance and outcome for the children treated. The study will also evaluate the improvement in treatment compliance and reporting. This work will help the group to evaluate future needs in participating units and help us adapt treatment programmes to local conditions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00001509 -
A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor
|
Phase 2 | |
| Not yet recruiting |
NCT04168788 -
Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL
|
N/A | |
| Recruiting |
NCT05245123 -
Psychosocial Situation of Children With Rare Solid Abdominal Tumors and Their Families
|
||
| Recruiting |
NCT05985161 -
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
|
Phase 2 |